Stamulumab (MYO-029) 10mg
Stamulumab is a monoclonal antibody designed to inhibit myostatin, aiming to increase muscle mass and function. It is investigational and not FDA-approved.
- The description claims that stamulumab aims to increase muscle mass and function.
- The description states that stamulumab is investigational and not FDA-approved.
Variants (1)
- Default Title — 4500.00 EUR — In stock
How AI sees this product
The more complete this product's details, the more confidently AI assistants can understand and recommend it.
66%